Japan

Cytokinetics inches forward with heart failure program
Cytokinetics inches forward with heart failure program
BioPharma Dive
Cytokinetics
Omecamtiv Mecarbil
Amgen
heart failure
Japan
Flag link:
Tesaro partners with Takeda in Asia, bagging a $340M deal for Zejula
Tesaro partners with Takeda in Asia, bagging a $340M deal for Zejula
Endpoints
Tesaro
Takeda
Japan
Zejula
Flag link:
Resolute Onyx drug-eluting stent launches in Japan
Resolute Onyx drug-eluting stent launches in Japan
Drug Delivery Business News
Resolute Onyx
drug-eluting stents
Japan
Medtronic
devices
Flag link:
Japan May Prove to Be Strong Growth Driver for AstraZeneca in 2017
Japan May Prove to Be Strong Growth Driver for AstraZeneca in 2017
Market Realist
Japan
AstraZeneca
Tagrisso
Flag link:
Takeda teams up with venture firm on drug discovery unit
Takeda teams up with venture firm on drug discovery unit
BioPharma Dive
Takeda
drug discovery
drug development
R&D
Japan
Scohia Pharma
Flag link:
AbbVie's Hepatitis C Treatment Under Priority Review in Japan
AbbVie's Hepatitis C Treatment Under Priority Review in Japan
Yahoo/GuruFocus
AbbVie
hepatitis C
Japan
glecaprevir/pibrentasvir
Flag link:
Daiichi shutters Japanese plant amid restructuring efforts
Daiichi shutters Japanese plant amid restructuring efforts
BioPharma Dive
Daiichi Sankyo
Japan
restructuring
Flag link:
On a deal spree, Takeda grabs Japanese cabo rights in $145M pact with Exelixis
On a deal spree, Takeda grabs Japanese cabo rights in $145M pact with Exelixis
Endpoints
Takeda
Japan
cabozantinib
Exelixis
Flag link:
Kite Pharma partners with Japan's Daiichi for cancer therapy
Kite Pharma partners with Japan's Daiichi for cancer therapy
Yahoo/Reuters
Kite Pharma
Japan
Daiichi Sankyo
axicabtagene ciloleucel
CAR-T
Flag link:
Japanese pharma snaps up cancer biotech Tolero
Japanese pharma snaps up cancer biotech Tolero
BioPharma Dive
Japan
Tolero Pharmaceuticals
M&A
Sumitomo Dainippon
Flag link:
Japan to review drug prices annually vs every two years previously -sources
Japan to review drug prices annually vs every two years previously -sources
Yahoo/Reuters
Japan
drug pricing
Flag link:
US complains to Japan about plans to cut drug prices
US complains to Japan about plans to cut drug prices
Stat
Japan
drug prices
Flag link:
Japan sets 50 pct price cut for Bristol Myers' Opdivo cancer drug
Japan sets 50 pct price cut for Bristol Myers' Opdivo cancer drug
Yahoo/Reuters
Japan
Bristol-Myers Squibb
Opdivo
drug pricing
non-small cell lung cancer
Flag link:
Bristol-Myers pens $100M NASH, fibrosis drug deal with Japan’s Nitto
Bristol-Myers pens $100M NASH, fibrosis drug deal with Japan’s Nitto
Fierce Biotech
Bristol-Myers Squibb
M&A
NASH
fibrosis
Japan
Nitto
Flag link:
Amgen And Daiichi Sankyo Announce Agreement To Commercialize Biosimilars In Japan
Amgen And Daiichi Sankyo Announce Agreement To Commercialize Biosimilars In Japan
Yahoo
Amgen
Daiichi Sankyo
Japan
biosimilars
Flag link:
Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in Japan
Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in Japan
Yahoo
Regeneron
Sanofi
Praluent
Japan
PCSK9 inhibitors
Flag link:
Daiichi snaps up Japanese rights to CVD stem-cell therapy
Daiichi snaps up Japanese rights to CVD stem-cell therapy
BioPharma Dive
Daiichi Sankyo
Japan
stem cells
Heartcel
Cell Therapy Group
Flag link:
Lilly shines in Japan in Q1, but CEO warns price cuts too deep
Lilly shines in Japan in Q1, but CEO warns price cuts too deep
Fierce Pharma
Eli Lilly
Japan
drug pricing
Pharma CEOs
John Lechleiter
Flag link:
Novo makes inroads in Japan with long-acting insulin Tresiba
Novo makes inroads in Japan with long-acting insulin Tresiba
Fierce Pharma
Japan
Novo Nordisk
diabetes
insulin
Tresiba
Flag link:
Drugmakers say Japan R&D spending at risk after government forces price cuts
Drugmakers say Japan R&D spending at risk after government forces price cuts
Yahoo/Reuters
Japan
R&D
Gilead Sciences
Sovaldi
Flag link: